Further action is required to make this featured image accessible
The below criteria must be satisfied:
- Add featured-image alt tag (in page properties OR on image metadata in the dam)
The image will not display until the issue above is resolved.
A study of emergency care involving victims of severe brain trauma is to be performed in this area
The University of Cincinnati is conducting a research study to learn if either of two strategies for monitoring and treating patients with severe traumatic brain injury in the intensive care unit (ICU) is more likely to help them get better. Because head injury is a life threatening condition requiring immediate treatment, some patients will be enrolled without consent if a family member or representative is not rapidly available. Before the study starts, we will consult with the community. We welcome your feedback and questions. For more information or to decline participation in this study, please visit boost3trial.org or contact our study staff at (513) 558-2678.
Primary Investigator: Dr. Natalie Kreitzer MD, Study Coordinator: Pamela Schmit RN BSN
Additional Contacts
Related Stories
Driven by curiosity, guided by care
May 14, 2026
Max Wilson, a University of Cincinnati College of Allied Health Sciences health sciences major on the pre-physician assistant track, found his path expanding beyond the classroom and into hands-on research focused on human performance and patient care.
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.